Bulenox offers & pricing

Bulenox's public offer is an evaluation product, not a deposit account. The fee buys access to a simulated account with a defined profit target and loss limit; clearing it converts you to a funded account paying up to 100% of simulated profit. The offer is a single-phase evaluation. You clear one profit target inside the loss buffer, then move to a funded account — no verification phase, no second fee.

Drawdown is the term that decides whether the offer is good value for your style. Bulenox uses a trailing limit that follows your intraday equity high, so unrealised profit permanently raises your stop-out floor even if you give it back. There is no consistency requirement gating withdrawals on the standard product.

Evaluation pricing starts around $50 with active discount codes pushing it lower, consistent with the budget futures segment. There is a recurring reset or activation cost structure typical of this cohort — check the current fee schedule for the specific account size and drawdown type you select.

Take the 100k account as the reference. Modelled list price is $70, or about $7 with the 90% public discount applied. At a 100% split you keep $1000 of every $1,000 in simulated profit, so the offer breaks even at roughly $7 of gross profit on the funded account — before you have earned anything.

Multiply that by your realistic pass rate. If you expect to clear the evaluation one time in three, the true cost of a funded 100k account is closer to $21, and break-even moves to about $21 in gross profit. That number, not the discount percentage, is the one to compare across firms.

The offer is only good value if you can survive the drawdown mechanic. On intraday trailing drawdown, the practical buffer on a 100k account is around 4% — treat that as your maximum campaign risk, not the number you trade up to.